Skip to content

AMN Healthcare AMN Stock repurchase program, authorized cumulative amount

Stock repurchase program, authorized cumulative amount at other companies

LGI Homes logo
LGI HomesLGIH
$200M
The Vita Coco Company, Inc. logo
The Vita Coco Company, Inc.COCO
$25M
Peapack-Gladstone Financial logo
Peapack-Gladstone FinancialPGC
5%
ACNB logo
ACNBACNB
3%
REX American Resources logo
REX American ResourcesREX
2.4M+368%
Lincoln Educational Services Corporation logo
Lincoln Educational Services CorporationLINC
$10M

Other financials

Income statement

See full
Revenue$1.4B+99.9%
Gross profit$368.8M+86.2%
Operating income$117.2M+837%
Net income$62.2M+5,793%
EPS (diluted)$1.59+5,400%

Balance sheet

See full
Cash & equivalents$595.0M+528%
Total debt$776.9M-12.4%
Total equity$712.8M-0.3%
Total assets$2.6B+8.7%

Cash flow

See full
Operating cash flow$562.5M+507%
CapEx$7.2M-27.4%
Free cash flow$555.2M+571%

Valuation

See full
Market cap$1.25B+49.8%
Enterprise value$1.44B-11.9%
P/S0.4×+0.1×

Profitability

See full
Gross margin27.6%-2.5pp
Operating margin-9.8%-14.2pp
Net margin-0.9%-0.4pp
FCF margin20.7%+11.6pp

Returns & leverage

See full
Return on equity-4.5%-2.0pp
Debt / equity1.1×-0.2×
Current ratio1.1×0.0×

Where this comes from

Reported directly by AMN Healthcare in its filing.

Tagged under the XBRL concept amn:StockRepurchaseProgramAuthorizedCumulativeAmount.

The official record: AMN Healthcare’s 10-K, filed February 22, 2024, on SEC EDGAR. View the filing →

Ask your AI about AMN Healthcare's stock repurchase program, authorized cumulative amount.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is AMN Healthcare's stock repurchase program, authorized cumulative amount?
AMN Healthcare (AMN) reported stock repurchase program, authorized cumulative amount of $500M in Q1 2023.
What does stock repurchase program, authorized cumulative amount mean?
The total dollar value of share repurchases authorized by the board of directors over the life of the program. This metric provides insight into the company's long-term capital allocation strategy and management's view on the intrinsic value of its stock.